These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 18318190

  • 1. [Anticoagulant activity of low-molecular-weight heparins obtained using a hydrolase complex].
    Drozd NN, Tolstenkov AS, Bannikova GE, Miftakhova NT, Lapikova ES, Makarov VA, Varlamov VP.
    Eksp Klin Farmakol; 2007; 70(6):19-24. PubMed ID: 18318190
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of low-molecular-weight heparin reversal by platelet factor 4.
    Fiore MM, Mackie IM.
    Thromb Res; 2009 May; 124(1):149-55. PubMed ID: 19195682
    [Abstract] [Full Text] [Related]

  • 3. M118--a rationally engineered low-molecular-weight heparin designed specifically for the treatment of acute coronary syndromes.
    Kishimoto TK, Qi YW, Long A, Capila I, Sasisekharan R, Guerrero L, Fier I, Roach J, Venkataraman G.
    Thromb Haemost; 2009 Nov; 102(5):900-6. PubMed ID: 19888526
    [Abstract] [Full Text] [Related]

  • 4. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V, Béguin S, Boneu B, Hemker HC.
    Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
    [Abstract] [Full Text] [Related]

  • 5. The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfate.
    Cosmi B, Agnelli G, Young E, Hirsh J, Weitz J.
    Thromb Haemost; 1993 Sep 01; 70(3):443-7. PubMed ID: 8259546
    [Abstract] [Full Text] [Related]

  • 6. The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effects.
    Harenberg J, Stehle G, Dempfle CE, von Hodenberg E, Heene DL.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989 Sep 01; 116(6):967-80. PubMed ID: 2483715
    [Abstract] [Full Text] [Related]

  • 7. Fibrinolytic and anticoagulant activity after a single subcutaneous administration of a low dose of heparin or a low molecular weight heparin-dihydroergotamine combination.
    Grimaudo V, Omri A, Kruithof EK, Hauert J, Bachmann F.
    Thromb Haemost; 1988 Jun 16; 59(3):388-91. PubMed ID: 2847348
    [Abstract] [Full Text] [Related]

  • 8. The correlation between plasma anti-factor Xa activity and haemostatic tests in healthy dogs, following the administration of a low molecular weight heparin.
    Mischke R, Grebe S.
    Res Vet Sci; 2000 Dec 16; 69(3):241-7. PubMed ID: 11124095
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Low molecular weight heparin is responsible for the anti-Xa activity of Desmin 370.
    Brieger D, Dawes J.
    Thromb Haemost; 1996 Feb 16; 75(2):286-91. PubMed ID: 8815578
    [Abstract] [Full Text] [Related]

  • 11. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ, Levi M, Nurmohamed MT, Büller HR, ten Cate JW.
    Thromb Haemost; 1994 Sep 16; 72(3):377-80. PubMed ID: 7855787
    [Abstract] [Full Text] [Related]

  • 12. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G, Brand P, Meyer T, Herpich C, Müllinger B, Brom J, Weidinger G, Kohlhäufl M, Häussinger K, Spannagl M, Schramm W, Siekmeier R.
    J Physiol Pharmacol; 2007 Nov 16; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [Abstract] [Full Text] [Related]

  • 13. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR, Mourão PA.
    Thromb Haemost; 2008 Mar 16; 99(3):531-8. PubMed ID: 18327401
    [Abstract] [Full Text] [Related]

  • 14. Heparin and low-molecular-weight heparin.
    Gray E, Mulloy B, Barrowcliffe TW.
    Thromb Haemost; 2008 May 16; 99(5):807-18. PubMed ID: 18449410
    [Abstract] [Full Text] [Related]

  • 15. Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin.
    Atkinson HM, Mewhort-Buist TA, Berry LR, Chan AK.
    Thromb Haemost; 2009 Jul 16; 102(1):62-8. PubMed ID: 19572069
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative human pharmacology of low molecular weight heparins.
    Harenberg J, Stehle G, Augustin J, Zimmermann R.
    Semin Thromb Hemost; 1989 Oct 16; 15(4):414-23. PubMed ID: 2554502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.